Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.
about
Variants in SNCA Gene Are Associated with Parkinson's Disease Risk and Cognitive Symptoms in a Brazilian Sample.Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.Analysis of LRRK2, SNCA, and ITGA8 Gene Variants with Sporadic Parkinson's Disease Susceptibility in Chinese Han Population.Nine-year experience in Gaucher disease diagnosis at the Spanish reference center Fundación Jiménez DíazSpecifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A ReviewTMEM230 in Parkinson's disease.Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?Genetic Architecture of MAPT Gene Region in Parkinson Disease Subtypes.Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments.Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels.Features of GBA-associated Parkinson's disease at presentation in the UK Tracking Parkinson's study.Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease.Regional analysis and genetic association of nigrostriatal degeneration in Lewy body disease.Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson's disease: a genetic association study.Integration of risk factors for Parkinson disease in 2 large longitudinal cohorts.Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease.A Comprehensive Analysis of the Association Between Polymorphisms and the Risk of Parkinson's DiseaseGlucocerebrosidase deficiency promotes protein aggregation through dysregulation of extracellular vesicles
P2860
Q33813336-E96FA3E0-4338-4B83-A1CF-6C5011D8E86CQ36815405-D778EEAE-4127-4B42-8182-526D9E128852Q37271108-B160B37D-2CBD-481D-BDDA-F4DDFD999976Q37414072-FD731B9E-510D-4B9D-9543-B498DE4F0016Q37593728-ECF769E6-60F0-4595-8C7E-BDE9B1D249EFQ38637878-B3FFC78C-7FCF-4E86-BBCE-B5EA23248EDDQ38812225-40B74BA7-5EDC-447D-9507-3F1C4A10CE13Q39151939-BBFDB473-D394-4133-A147-B0741F82105BQ40012093-6C7820E9-186F-4B8A-B9EC-D11D943FBC00Q40603461-FC6EAB1D-B5D9-4EA0-B176-45B0DBAA98C8Q45873810-9ECEE2C4-2FCA-4D32-980D-CAC763C0A95AQ45915163-07F3BB0D-F6F5-4173-A6AD-98B5EDB22072Q47552228-940C9E3F-B2C0-4572-9361-445B6DE9BD55Q47555107-6E54C6C3-6344-41CA-A3D0-B1B22A5B090DQ48288262-3F37F5B7-E537-437B-A15B-55AE19F611E7Q50281673-5696E68C-A9AB-468E-8541-76AF92C2DC1BQ53074377-D35643DB-1AAC-4DE4-86E0-6C09A2ABD1C7Q53397478-18377457-8749-4693-8071-6DA883078931Q58556450-C78B067D-D030-45CB-BCAA-E2F914B2ECC1Q58693990-C9005587-D376-425F-A6BB-5B379AB72C93
P2860
Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Variants in GBA, SNCA, and MAP ...... age at onset, and progression.
@ast
Variants in GBA, SNCA, and MAP ...... age at onset, and progression.
@en
type
label
Variants in GBA, SNCA, and MAP ...... age at onset, and progression.
@ast
Variants in GBA, SNCA, and MAP ...... age at onset, and progression.
@en
altLabel
Variants in GBA , SNCA , and M ...... age at onset, and progression
@en
prefLabel
Variants in GBA, SNCA, and MAP ...... age at onset, and progression.
@ast
Variants in GBA, SNCA, and MAP ...... age at onset, and progression.
@en
P2093
P2860
P50
P1476
Variants in GBA, SNCA, and MAP ...... age at onset, and progression.
@en
P2093
Albert A Davis
Brad A Racette
Kristin M Andruska
P2860
P304
209.e1-209.e7
P356
10.1016/J.NEUROBIOLAGING.2015.09.014
P577
2015-09-30T00:00:00Z